Merav Bassan
Corporate Officer/Principal bij BIOMX INC.
Vermogen: - $ op 31-03-2024
Profiel
Merav Bassan is currently the Chief Development Officer at BiomX Ltd.
and BiomX, Inc. She is also a member of 8400 Health Network.
Previously, she worked at Teva Pharmaceutical Industries Ltd.
as Vice President from 2009 to 2019.
She received her undergraduate and graduate degrees from Tel-Aviv University and her doctorate from Sackler School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOMX INC.
-.--% | 11-12-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Merav Bassan
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 28-10-2019 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01-10-2019 |
| 8400 Health Network | Corporate Officer/Principal | - |
Eerdere bekende functies van Merav Bassan
| Bedrijven | Functie | Einde |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Merav Bassan
| Tel-Aviv University | Graduate Degree |
| Sackler School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOMX INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
| 8400 Health Network |
